The other group comprises PKMTs with both oncogenic and tumor-suppressive functions, including DOT1L, EZH2, MLL2, MLL4, NSD1, SETD2, SETD3, SETDB1, and PRDM16. This evidence concerns the gene EZH2 and neoplasm.